Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis

Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922

July 1, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922

Why Bank Of America Shares Are Falling Tuesday

January 17, 12:06 PM

Bank of America Corp (NYSE: BAC) shares are trading lower by 2.68% to $34.29 Tuesday morning after Piper Sandler downgraded the stock to Underweight.

November 6, 10:34 AM

During a recession, investors should seek firms with solid fundamentals and a strong track record of better-than-expected earnings performances.

January 12, 6:24 AM

Logitech International S.A. (NASDAQ:LOGI) shared preliminary results ranges for the third quarter of FY23 ended on December 31, 2022. Preliminary…

February 22, 9:23 AM

Citigroup analyst Scott Gruber maintains Nabors Industries (NYSE:NBR) with a Buy and lowers the price target from $210 to $200.